Preliminary scientific tests show conolidine may inhibit unique ion channels, minimizing neuronal excitability and restricting agony alerts. This mechanism is especially pertinent in neuropathic suffering, exactly where irregular signaling leads to persistent soreness. Also, conolidine appears to impact G protein-coupled receptor (GPCR) pathways in